What assessment tools are recommended for evaluating opioid use disorder in hospitalized patients?

Assessment Tools for Opioid Use Disorder in Hospitalized Patients

For hospitalized patients, use the DSM-5 criteria to diagnose opioid use disorder, supplemented by the Current Opioid Misuse Measure (COMM) for those already on opioids, while the Opioid Risk Tool (ORT) and SOAPP-R are designed for outpatient risk stratification and have limited applicability in acute inpatient settings. 1, 2

Diagnostic Approach in the Inpatient Setting

The primary assessment tool for hospitalized patients is the DSM-5 diagnostic criteria for opioid use disorder, which should be applied when clinicians suspect OUD based on patient concerns, behaviors, or clinical findings 2. This represents the gold standard for diagnosis rather than screening tools designed for outpatient risk assessment.

Available Assessment Instruments

For patients already prescribed opioids:

• Current Opioid Misuse Measure (COMM): A 17-question self-assessment specifically designed to identify ongoing misuse in patients currently taking opioids 1. This tool has demonstrated feasibility in the inpatient setting, with studies showing it can identify aberrant opioid use among hospitalized patients 3.

For initial risk stratification (primarily outpatient-focused):

• Opioid Risk Tool (ORT): Brief validated questionnaire assigning sex-specific scores based on five risk factors: personal history of substance abuse, family history of substance abuse, younger age, mental illness, and history of preadolescent sexual abuse 1
• Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): 24-item tool empirically derived to predict future aberrant opioid use 1, 4

Critical Implementation Considerations

Important caveat: These screening tools were developed and validated primarily for outpatient chronic pain management settings, not acute hospital care 1. Their role in the inpatient setting is to supplement—not replace—clinical assessment, physical examination, and direct patient interviews 1.

What to Assess During Hospitalization

When evaluating hospitalized patients for OUD, focus on:

• Withdrawal symptoms: Use validated scales like the Clinical Opiate Withdrawal Scale (COWS) or Subjective Opiate Withdrawal Scale (SOWS) to objectively measure withdrawal severity 5
• Behavioral indicators: Self-directed discharge, code white events, requests for specific opioids, and patterns of medication use 6
• Prescription Drug Monitoring Program (PDMP) data: Review for high-risk combinations, multiple prescribers, or concerning dosages 2, 4
• Urine drug screening: Combine with clinical assessment, recognizing that standard screens may miss synthetic opioids like oxycodone and buprenorphine, which require specific assays 7, 8

Practical Algorithm for Inpatient Assessment

1. Screen all hospitalized patients with known or suspected opioid use using DSM-5 criteria
2. For patients on home opioid regimens: Administer COMM to detect ongoing misuse
3. Assess for withdrawal: Use COWS or SOWS within 2-3 half-lives of last opioid dose (symptoms typically peak at 48-72 hours) 5
4. Review PDMP data when available
5. Obtain targeted urine drug screen with specific assays for suspected substances
6. Conduct structured patient interview exploring drug/alcohol history, pain patterns, and home medication safety

Common Pitfalls to Avoid

• Do not rely solely on screening tools without clinical context—they have variable sensitivity and specificity 8
• Do not withhold assessment due to stigma or assumptions about patient reliability
• Do not delay opioid agonist therapy while waiting for formal assessment completion—withdrawal management should begin promptly 2, 9
• Do not use risk stratification tools to deny treatment—they inform intensity of monitoring and need for specialist consultation, not treatment eligibility 1

Evidence Quality Note

The guidelines consistently emphasize that no single assessment tool demonstrates both high interobserver reliability and high sensitivity 8. However, a standardized approach using validated instruments remains superior to subjective clinician judgment alone. Most recommendations are based on observational studies and expert consensus rather than high-quality randomized trials 4, 10.

For patients identified with OUD, immediately offer or arrange medication-assisted treatment with buprenorphine or methadone rather than focusing solely on assessment—treatment initiation during hospitalization represents a critical opportunity to engage patients in evidence-based care 2, 9, 10.